Virginia Commonwealth University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).

558 total trials 77 currently recruiting 380 completed early-phase tilt top decile by trial count

Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.

Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.

Top-decile sponsor footprint

Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 45/100

380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

558 total, page 5 of 12

COMPLETED NA

The Effect of Electronic Cigarette Liquid Characteristics in Smokers.

NCT03861078

COMPLETED Early Phase 1

Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis

NCT04166396

TERMINATED NA

Evaluating Outcomes for Youth Receiving Hospital-based Violence Prevention With and Without a Community-level Initiative

NCT04192318

COMPLETED NA

Mobile-Based Contingency Management to Promote Daily Self-monitoring in Primary Care Patients

NCT03962491

TERMINATED NA

Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease

NCT04587193

TERMINATED NA

Colorectal Health Research Champions

NCT04812743

TERMINATED NA

Eudaimonia and Sleep: Effects of a Mindfulness Intervention in Caregivers of People With Dementia

NCT03857308

COMPLETED NA

The Effect Of Virtual Reality Glasses On The Behavior Of Children With Autism Spectrum Disorder

NCT03853265

COMPLETED Phase 1

Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia

NCT03964259

COMPLETED NA

Education Nutritional Video for Gestational Diabetics

NCT03859193

COMPLETED NA

Culturally Enhancing a Motivational Interviewing Intervention For Latinx Adolescents

NCT03947177

COMPLETED NA

Assessing the Effects of Auricular Acupressure on Newborns With NAS

NCT03890562

TERMINATED Phase 2

Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric

NCT03962634

COMPLETED NA

Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction

NCT03960073

COMPLETED NA

24-Hour Ambulatory Blood Pressure Monitoring in Community Pharmacies

NCT03920956

COMPLETED NA

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Obesity and HFpEF

NCT03966755

COMPLETED NA

Feasibility of Delivering an Avatar Life-review Intervention to Support Patients With Active Cancer

NCT03996642

COMPLETED NA

The BMI Project (Body, Mind, Inflammation)

NCT04023318

COMPLETED NA

Transition Preparation Intervention for Young Adults With Type 1 Diabetes

NCT03998475

COMPLETED

Sickle Cell Uric Acid (SCUA) - Cohort Repository

NCT04190888

COMPLETED Early Phase 1

Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease

NCT03819517

COMPLETED NA

Brain Function and Decision-Making

NCT03974282

COMPLETED NA

Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1

NCT03958734

COMPLETED

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

NCT03981289

COMPLETED Phase 1

Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence

NCT02120365

TERMINATED Phase 1

The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients

NCT03805360

COMPLETED NA

Parent Involvement in Adolescent Obesity Treatment

NCT03851796

COMPLETED NA

Stress and Feeding (SAFE): A Pilot Intervention for Mothers and Their Preterm Infants

NCT03664154

COMPLETED NA

Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx

NCT03923504

COMPLETED NA

Kids 2 Be & Breathe: A Study on the Use of Yoga and Mindfulness in Children With Severe Asthma (K2B2)

NCT03752164

COMPLETED NA

Embodied Empathy; Virtual Reality and Experiencing Geriatrics

NCT03987269

COMPLETED Phase 2

Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis

NCT03829683

COMPLETED NA

Self-Managed Intervention for Anxiety in Parkinson's Disease

NCT03859180

TERMINATED Phase 2

Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease

NCT03865407

COMPLETED NA

Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

NCT03848884

COMPLETED NA

Vibration Impact on Parkinson's Tremor

NCT03799614

COMPLETED

Salad Bars in the National School Lunch Program: Impact on Dietary Consumption Patterns in Elementary School Students

NCT05605483

COMPLETED NA

The Effectiveness of Bilateral Alternating Tactile Stimulation for Improving Sleep in Children

NCT03805334

COMPLETED NA

Effects of Active Reminders and Motivational Techniques on Oral Hygiene and Gingival Health in Orthodontic Patients

NCT03841825

TERMINATED NA

Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers

NCT03830892

COMPLETED NA

Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users

NCT03710590

COMPLETED NA

The VIGOR Study - Virtual Immersive Gaming to Optimize Recovery in Low Back Pain

NCT03463824

COMPLETED Phase 2

Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2

NCT03797001

TERMINATED Phase 3

Virginia Opioid Overdose Treatment InitiatVE

NCT03818399

COMPLETED NA

Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain

NCT03851978

COMPLETED NA

Improving Emotion Regulation in Adolescents With ADHD

NCT03733548

COMPLETED NA

Developing and Examining Evidenced-Based HIV Testing Messages

NCT03433053

COMPLETED NA

CBT4CBT for Women in Residential Treatment for Substance Use Disorders

NCT03678051

COMPLETED Phase 2

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

NCT03613727

COMPLETED NA

Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome

NCT03542240

← Previous Page 5 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 80
Phase 2 65
Phase 3 13
Phase 4 22

What is open in the Virginia Commonwealth University pipeline

77 recruiting of 558 indexed (14% open); 380 completed (68%).

Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).

Top condition: Obesity (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Virginia Commonwealth University: open-pipeline peers nationwide

Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Virginia Commonwealth UniversityAmgenMerck Sharp & DohmeUniversity of Maryland, BaltimoreOhio State UniversityLindenwood UniversityBeiGeneReproductive Medicine Associates of New JerseyUniversity of Cincinnati
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 558 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Virginia Commonwealth University page

558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.

  • 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.